Harbin Medisan Pharmaceutical Co Ltd Strategic Asset Allocation Index
Harbin Medisan Pharmaceutical Co Ltd strategic asset allocation index. Harbin Medisan Pharmaceutical Co Ltd (002900) has a Strategic Asset Allocation Index of 47.6% as of September 2023. Strategic assets (PP&E of CN¥1.02 Billion plus long-term investments of CN¥-) total CN¥1.02 Billion, measured against net assets of CN¥2.13 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 002900 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Harbin Medisan Pharmaceutical Co Ltd (2016–2021)
Strategic asset allocation index of Harbin Medisan Pharmaceutical Co Ltd from 2016 to 2021. This chart shows how Harbin Medisan Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2021. As of September 2023, the index stands at 47.6%, representing strategic assets of CN¥1.02 Billion against net assets of CN¥2.13 Billion CNY.
Harbin Medisan Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2016–2021)
Harbin Medisan Pharmaceutical Co Ltd strategic asset allocation index by year from 2016 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Harbin Medisan Pharmaceutical Co Ltd from 2016 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Harbin Medisan Pharmaceutical Co Ltd market cap and net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 43.7% | CN¥925.35 Million | CN¥925.35 Million | CN¥- | CN¥2.12 Billion | ▼ -4.7 pp |
| 2020 | 48.4% | CN¥867.29 Million | CN¥867.29 Million | CN¥- | CN¥1.79 Billion | ▲ +4.8 pp |
| 2019 | 43.6% | CN¥806.69 Million | CN¥806.69 Million | CN¥- | CN¥1.85 Billion | ▲ +6.7 pp |
| 2018 | 36.8% | CN¥725.71 Million | CN¥725.71 Million | CN¥- | CN¥1.97 Billion | ▼ -2.5 pp |
| 2017 | 39.3% | CN¥721.72 Million | CN¥721.72 Million | CN¥- | CN¥1.83 Billion | ▼ -50.1 pp |
| 2016 | 89.4% | CN¥722.60 Million | CN¥722.60 Million | CN¥- | CN¥808.17 Million | — |